Search Within

Neeta Pandit-Taskar

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (21)
  3. Book Section (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (44)
  2. GSK Faculty (44)
  3. Molecular Imaging and Therapy Service (44)
  4. Radiology, Department of (44)
  5. Radiochemistry and Imaging Sciences Service (30)
  6. Department of Medicine (28)

More Groups

People
  1. Steven Larson (22)
  2. Jason Lewis (21)
  3. Jorge Carrasquillo (19)
  4. Joseph O'Donoghue (14)
  5. Serge Lyashchenko (14)
  6. Wolfgang Weber (12)

More People

Years
  1. 2022 (3)
  2. 2021 (3)
  3. 2020 (5)
  4. 2019 (4)
  5. 2018 (6)
  6. 2016 (3)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Journal of Nuclear Medicine (8)
  3. European Journal of Nuclear Medicine and Molecular Imaging (5)
  4. Blood (4)
  5. Clinical Cancer Research (4)
  6. Pediatric Blood and Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Society of Nuclear Medicine (8)
  3. American Association for Cancer Research (6)
  4. Springer (5)
  5. American Society of Hematology (4)
  6. Wiley Periodicals, Inc (3)

More Publishers

Results (44)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequential cytarabine and alpha-particle immunotherapy with bismuth-213 ((213)Bi)-labeled-HuM195 (lintuzumab) for acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T.; McDevitt, M. R.; Mulford, D. A.; Pandit-Taskar, N.; Weiss, M. A.; Heaney, M. L.; Chanel, S.; Morgenstern, A.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)
    Meeting Abstract

    Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • Alpha-particle immunotherapy for acute myeloid leukemia (AML) with bismuth-213 and actinium-225
    Meeting Abstract

    Jurcic, J. G.; McDevitt, M. R.; Pandit-Taskar, N.; Divgi, C. R.; Finn, R. D.; Sgouros, G.; Apostalidis, C.; Chanel, S.; Larson, S. M.; Scheinberg, D. A.
    Cancer Biotherapy and Radiopharmaceuticals (2006)

    Fulltext@MSK | Save
  • Sequential therapy with cytarabine and bismuth-213 (Bi-213)-labeled-HuM195 (anti-CD33) for acute myeloid leukemia (AML)
    Meeting Abstract

    Mulford, D. A.; Pandit-Taskar, N.; McDevitt, M. R.; Finn, R. D.; Weiss, M. A.; Apostolidis, C.; Morgenstern, A.; Divgi, C. R.; Larson, S. M.; Scheinberg, D. A.; more...
    Blood (2004)

    Fulltext@MSK | Save